Coherus Oncology Statistics

Total Valuation

CHRS has a market cap or net worth of $145.05 million. The enterprise value is $7.70 million.

Market Cap	145.05M
Enterprise Value	7.70M

Important Dates

The last earnings date was Thursday, November 6, 2025, after market close.

Earnings Date	Nov 6, 2025
Ex-Dividend Date	n/a

Share Statistics

CHRS has 120.87 million shares outstanding. The number of shares has increased by 2.22% in one year.

Current Share Class	120.87M
Shares Outstanding	120.87M
Shares Change (YoY)	+2.22%
Shares Change (QoQ)	+0.13%
Owned by Insiders (%)	6.50%
Owned by Institutions (%)	46.79%
Float	112.99M

Valuation Ratios

The trailing PE ratio is 2.28.

PE Ratio	2.28
Forward PE	n/a
PS Ratio	0.50
Forward PS	1.71
PB Ratio	1.59
P/TBV Ratio	3.79
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	0.05
EV / Sales	0.03
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.24, with a Debt / Equity ratio of 0.62.

Current Ratio	1.24
Quick Ratio	1.19
Debt / Equity	0.62
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-3.34

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-10.26%
Return on Invested Capital (ROIC)	-29.64%
Return on Capital Employed (ROCE)	-58.14%
Revenue Per Employee	$1.22M
Profits Per Employee	$679,697
Employee Count	228
Asset Turnover	0.54
Inventory Turnover	4.88

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -29.82% in the last 52 weeks. The beta is 0.96, so CHRS's price volatility has been similar to the market average.

Beta (5Y)	0.96
52-Week Price Change	-29.82%
50-Day Moving Average	1.50
200-Day Moving Average	1.11
Relative Strength Index (RSI)	41.95
Average Volume (20 Days)	1,291,679

Short Selling Information

The latest short interest is 29.18 million, so 24.14% of the outstanding shares have been sold short.

Short Interest	29.18M
Short Previous Month	30.10M
Short % of Shares Out	24.14%
Short % of Float	25.82%
Short Ratio (days to cover)	23.32

Income Statement

In the last 12 months, CHRS had revenue of $277.73 million and earned $154.97 million in profits. Earnings per share was $1.34.

Revenue	277.73M
Gross Profit	156.38M
Operating Income	-83.85M
Pretax Income	61.03M
Net Income	154.97M
EBITDA	-79.79M
EBIT	-83.85M
Earnings Per Share (EPS)	$1.34

Full Income Statement

Balance Sheet

The company has $191.66 million in cash and $54.32 million in debt, giving a net cash position of $137.34 million or $1.14 per share.

Cash & Cash Equivalents	191.66M
Total Debt	54.32M
Net Cash	137.34M
Net Cash Per Share	$1.14
Equity (Book Value)	87.77M
Book Value Per Share	0.76
Working Capital	88.66M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-90.19M
Capital Expenditures	n/a
Free Cash Flow	-90.19M
FCF Per Share	-$0.75

Full Cash Flow Statement

Margins

Gross margin is 56.31%, with operating and profit margins of -30.19% and 55.80%.

Gross Margin	56.31%
Operating Margin	-30.19%
Pretax Margin	21.98%
Profit Margin	55.80%
EBITDA Margin	-28.73%
EBIT Margin	-30.19%
FCF Margin	n/a

Dividends & Yields

CHRS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.22%
Shareholder Yield	-2.22%
Earnings Yield	106.84%
FCF Yield	-62.18%

Analyst Forecast

The average price target for CHRS is $4.51, which is 275.83% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$4.51
Price Target Difference	275.83%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	5.82%
EPS Growth Forecast (5Y)	-9.96%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CHRS has an Altman Z-Score of -3.27 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.27
Piotroski F-Score	4